Lupin announced that it has received tentative approval for its Efinaconazole Topical Solution, 10%, from the United States Food and Drug Administration, to market a generic equivalent of Jublia Topical Solution, 10%, of Bausch Health Americas, Inc.
Efinaconazole Topical Solution, 10%, is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes. Efinaconazole Topical Solution, 10%, (RLD: Jublia) had estimated annual sales of $222.9 million in the U.S. (IQVIA MAT September 2020).
The announcement was made after market hours on Thursday, 24 December 2020. Shares of Lupin rose 1.37% to settle at Rs 976.15 on Thursday.
The stock hit a 52-week high of Rs 1121.85 on 18 September 2020. The stock hit a 52-week low of Rs 505 on 13 March 2020.
Lupin has received tentative approval for its Efinaconazole Topical Solution, 10%, from the United States Food and Drug Administration, to market a generic equivalent of Jublia Topical Solution, 10%,
of Bausch Health Americas, Inc.
Efinaconazole Topical Solution, 10%, is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Efinaconazole Topical Solution, 10%, (RLD: Jublia) had estimated annual sales of USD 222.9 million in the U.
S.
(IQVIA MAT September 2020).
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offer
Dr. Peter Hotez Doom and Gloom
This article is from an interview with Dr. Peter Hotez on NPR last month. The Tweet in the photo is from yesterday. Dr Hotez jubilantly taking a CoVax. I expect his tie to spin with giddy delight. Moderna and Pfizer vaccines are starting to be delivered and administered as of this week. Imagine any doctor stating that we need to vaccinate THE ENTIRE WORLD POPULATION. What on earth is that? The assumption is safety and efficacy for billions, which is impossible nonsense. The reality is that the damage and danger is considered “worth it.” Vaccines are now a bona fide religion, a cult requiring compliance, no questions, no choice. MMR bows before CoVax as the new god on the block. This is a frightening road, no matter what your thoughts on vaccination, all, some, none. Never before has the world been told to fall into step like this, so fast. In 10 months, life has been radically changed and now we need a vacccine. Why does the mainstream accept
Pharmaceutical Drug Delivery Market SWOT Analysis by Key openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.